Search

Search Results
Results 2541 - 2550 of 4527 for multiple sclerosis
  • Natalizumab returns to market
    News - 28 May 2007
    Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after...
  • FDA needs authority to approve generic biologics
    News - 8 Mar 2007
    AARP called on Congress today to give the Food and Drug Administration (FDA) the authority to approve safe, cost-effective generic versions of often expensive biologic drug therapies.
  • Scientists identifiy key compounds that stimulate stem cell growth in the brain
    News - 4 Sep 2006
    Scientists at Harvard University have identified key compounds that stimulate stem cell growth in the brain, which may one day lead to restored function for people affected by Parkinson's disease,...
  • Novel way to treat stroke
    News - 9 Jan 2006
    A joint research effort between researchers at the Burnham Institute for Medical Research in La Jolla, CA, and a team from Japan (Iwate University, Osaka City University, Gifu University, Iwate...
  • Findings may help in development of new anti-inflammatory compounds
    News - 2 Dec 2005
    Virginia Commonwealth University researchers studying the enzyme that triggers inflammation have found that it may be a target for a new class of anti-inflammatory drugs to treat arthritis, asthma,...
  • New insight into autoimmune disease
    News - 21 Jun 2005
    The immune system is a complex and powerful weapon that provides protection against bacteria and viruses that, if left unchecked, would wreak havoc throughout the human body.
  • Immunomedics awarded U.S. and Australian patents
    News - 16 Jun 2005
    Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of...
  • Cell replacement therapy offers a novel and powerful medical technology
    News - 13 Dec 2004
    Cell replacement therapy offers a novel and powerful medical technology. A type of embryonic stem cell, called a neural crest stem cell, that persists into adulthood in hair follicles was recently...
  • Relatively little is known about Lupus
    News - 1 Jul 2004
    Doctors have today launched an appeal for volunteers to take part in a new study into the widespread, yet largely unknown, autoimmune disease, SLE or Lupus.
  • Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation
    News - 29 Jun 2004
    Oxford University's Therapeutic Antibody Centre (TAC) has received a Manufacturer's Authorisation (Investigational Medicinal Products) from the Medicines and Healthcare Products Regulatory Agency...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback